Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
2-hydroxyoleic acid (2 trials)
temozolomide (temodar) (1 trial)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Trials (2 total)
Trial APIs (2 total)